Literature DB >> 11533067

Serum amyloid P component is the Shiga toxin 2-neutralizing factor in human blood.

T Kimura1, S Tani, Y Matsumoto Yi, T Takeda.   

Abstract

It has been suggested that some factor present in human plasma binds to Shiga toxin 2 (Stx2) and neutralizes it in vitro (Bitzan, M., Klemt, M., Steffens, R., and Muller-Wiefel, D. E. (1993) Infection 21, 140-145). This factor does not exist in other species (Caprioli, A., Luzzi, I., Seganti, L., Marchetti, M., Karmali, M., Clarke, I., and Boyd, B. (1994) Recent Adv. VTEC Infect. 353-356). Because analysis of this factor is important to understanding the pathology induced by Shiga toxin-producing Escherichia coli, we purified this factor from human plasma and identified it. Purification was carried out by serially subjecting human plasma to Con A-Sepharose, DEAE-Sepharose, hydroxyapatite, and gel-filtration high performance liquid chromatography (HPLC), using Stx2-neutralizing activity as the indicator. The gel-filtration HPLC fraction yielded a single band on SDS-polyacrylamide gel electrophoresis. Twenty N-terminal amino acid residues of this fraction were analyzed and found to correspond perfectly to human serum amyloid P component (HuSAP). Because commercially available HuSAP also showed Stx2 binding and neutralizing activity, we identified this factor as HuSAP.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11533067     DOI: 10.1074/jbc.M107819200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Serum amyloid P component binding to Shiga toxin 2 requires both a subunit and B pentamer.

Authors:  Paola Marcato; Kathleen Vander Helm; George L Mulvey; Glen D Armstrong
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

2.  In vivo supramolecular templating enhances the activity of multivalent ligands: a potential therapeutic against the Escherichia coli O157 AB5 toxins.

Authors:  Pavel I Kitov; George L Mulvey; Thomas P Griener; Tomasz Lipinski; Dmitry Solomon; Eugenia Paszkiewicz; Jared M Jacobson; Joanna M Sadowska; Missao Suzuki; Ken-Ichi Yamamura; Glen D Armstrong; David R Bundle
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-27       Impact factor: 11.205

Review 3.  Shiga Toxin (Stx) Classification, Structure, and Function.

Authors:  Angela R Melton-Celsa
Journal:  Microbiol Spectr       Date:  2014-08

4.  Role of tumor necrosis factor alpha in disease using a mouse model of Shiga toxin-mediated renal damage.

Authors:  Erin K Lentz; Rama P Cherla; Valery Jaspers; Bradley R Weeks; Vernon L Tesh
Journal:  Infect Immun       Date:  2010-07-06       Impact factor: 3.441

5.  Protection of human podocytes from shiga toxin 2-induced phosphorylation of mitogen-activated protein kinases and apoptosis by human serum amyloid P component.

Authors:  Anne K Dettmar; Elisabeth Binder; Friederike R Greiner; Max C Liebau; Christine E Kurschat; Therese C Jungraithmayr; Moin A Saleem; Claus-Peter Schmitt; Elisabeth Feifel; Dorothea Orth-Höller; Markus J Kemper; Mark Pepys; Reinhard Würzner; Jun Oh
Journal:  Infect Immun       Date:  2014-02-24       Impact factor: 3.441

6.  Pneumolysin-dependent and -independent gene expression identified by cDNA microarray analysis of THP-1 human mononuclear cells stimulated by Streptococcus pneumoniae.

Authors:  P David Rogers; Justin Thornton; Katherine S Barker; D Olga McDaniel; Gordon S Sacks; Edwin Swiatlo; Larry S McDaniel
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

Review 7.  The interactions of human neutrophils with shiga toxins and related plant toxins: danger or safety?

Authors:  Maurizio Brigotti
Journal:  Toxins (Basel)       Date:  2012-03-01       Impact factor: 4.546

8.  Lipopolysaccharide renders transgenic mice expressing human serum amyloid P component sensitive to Shiga toxin 2.

Authors:  Thomas P Griener; Jonathan G Strecker; Romney M Humphries; George L Mulvey; Carmen Fuentealba; Robert E W Hancock; Glen D Armstrong
Journal:  PLoS One       Date:  2011-06-24       Impact factor: 3.240

9.  Interactions of Shiga-like toxin with human peripheral blood monocytes.

Authors:  Joyce M Geelen; Thea J A M van der Velden; Lambertus P W J van den Heuvel; Leo A H Monnens
Journal:  Pediatr Nephrol       Date:  2007-05-22       Impact factor: 3.714

Review 10.  Pentraxins: structure, function, and role in inflammation.

Authors:  Terry W Du Clos
Journal:  ISRN Inflamm       Date:  2013-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.